Health Belief Model Perspective on the Control of COVID-19 Vaccine Hesitancy and the Promotion of Vaccination in China: Web-Based Cross-sectional Study

被引:81
作者
Chen, Hao [1 ]
Li, Xiaomei [1 ]
Gao, Junling [1 ]
Liu, Xiaoxi [1 ]
Mao, Yimeng [1 ]
Wang, Ruru [1 ]
Zheng, Pinpin [1 ]
Xiao, Qianyi [1 ]
Jia, Yingnan [1 ]
Fu, Hua [1 ]
Dai, Junming [1 ]
机构
[1] Fudan Univ, Sch Publ Hlth, Dept Prevent Med & Hlth Educ, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
COVID-19; pandemic; vaccination behavior; vaccine hesitancy; health belief model; HUMAN-PAPILLOMAVIRUS VACCINE; INFLUENZA VACCINATION; IMPLEMENTATION INTENTIONS; PARENTAL ACCEPTANCE; BEHAVIOR; COMMUNICATION; DETERMINANTS; WILLINGNESS; PREDICT; SPREAD;
D O I
10.2196/29329
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The control of vaccine hesitancy and the promotion of vaccination are key protective measures against COVID-19. Objective: This study assesses the prevalence of vaccine hesitancy and the vaccination rate and examines the association between factors of the health belief model (HBM) and vaccination. Methods: A convenience sample of 2531 valid participants from 31 provinces and autonomous regions of mainland China were enrolled in this online survey study from January 1 to 24, 2021. Multivariable logistic regression was used to identify the associations of the vaccination rate and HBM factors with the prevalence of vaccine hesitancy after other covariates were controlled. Results: The prevalence of vaccine hesitancy was 44.3% (95% CI 42.3%-46.2%), and the vaccination rate was 10.4% (9.2%-11.6%). The factors that directly promoted vaccination behavior were a lack of vaccine hesitancy (odds ratio [OR] 7.75, 95% CI 5.03-11.93), agreement with recommendations from friends or family for vaccination (OR 3.11, 95% CI 1.75-5.52), and absence of perceived barriers to COVID-19 vaccination (OR 0.51, 95% CI 0.35-0.75). The factors that were directly associated with a higher vaccine hesitancy rate were a high level of perceived barriers (OR 1.63, 95% CI 1.36-1.95) and perceived benefits (OR 0.51, 95% CI 0.32-0.79). A mediating effect of self-efficacy, influenced by perceived barriers (standardized structure coefficient [SSC]=-0.71, P<.001), perceived benefits (SSC=0.58, P<.001), agreement with recommendations from authorities (SSC=0.27, P<.001), and agreement with recommendations from friends or family (SSC=0.31, P<.001), was negatively associated with vaccination (SSC=-0.45, P<.001) via vaccine hesitancy (SSC=-0.32, P<.001). Conclusions: It may be possible to increase the vaccination rate by reducing vaccine hesitancy and perceived barriers to vaccination and by encouraging volunteers to advocate for vaccination to their friends and family members. It is also important to reduce vaccine hesitancy by enhancing self-efficacy for vaccination, due to its crucial mediating function.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity
    Liu, Ying
    Han, Junyan
    Li, Xin
    Chen, Danying
    Zhao, Xuesen
    Qiu, Yaruo
    Zhang, Leidan
    Xiao, Jing
    Li, Bei
    Zhao, Hongxin
    VACCINES, 2021, 9 (12)
  • [22] The Prevalence of COVID-19 Vaccination and Vaccine Hesitancy in Pregnant Women: An Internet-based Cross-sectional Study in Japan
    Hosokawa, Yoshihiko
    Okawa, Sumiyo
    Hori, Ai
    Morisaki, Naho
    Takahashi, Yoko
    Fujiwara, Takeo
    Nakayama, Shoji F.
    Hamada, Hiromi
    Satoh, Toyomi
    Tabuchi, Takahiro
    JOURNAL OF EPIDEMIOLOGY, 2022, 32 (04) : 188 - 194
  • [23] Factors associated with COVID-19 vaccine hesitancy among healthcare workers in Cameroon and Nigeria: a web-based cross-sectional study
    Aseneh, Jerry Brown
    Agbor, Valirie Ndip
    Kadia, Benjamin Momo
    Okolie, Elvis Anyaehiechukwu
    Ofomata, Chinelo Janefrances
    Etombi, Christie Linonge
    Ekaney, Domin Sone M.
    Fru, Yvonne Walburga Joko
    INTERNATIONAL HEALTH, 2023, 15 (06): : 702 - 714
  • [24] Prevalence and factors associated with COVID-19 vaccine acceptance in Zambia: a web-based cross-sectional study
    Mudenda, Steward
    Hikaambo, Christabel Nang'andu
    Daka, Victor
    Chileshe, Misheck
    Mfune, Ruth Lindizyani
    Kampamba, Martin
    Kasanga, Maisa
    Phiri, Margaret
    Mufwambi, Webrod
    Banda, Michelo
    Phiri, Maureen Nkandu
    Mukosha, Moses
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41
  • [25] COVID-19 vaccine hesitancy in the UK: a longitudinal household cross-sectional study
    Kausik Chaudhuri
    Anindita Chakrabarti
    Joht Singh Chandan
    Siddhartha Bandyopadhyay
    BMC Public Health, 22
  • [26] COVID-19 vaccine hesitancy in Ethiopia in 2021: a multicenter cross-sectional study
    Erega, Besfat Berihun
    Ferede, Wassie Yazie
    Sisay, Fillorenes Ayalew
    Tiruneh, Gebrehiwot Ayalew
    Ayalew, Abeba Belay
    Malka, Erean shigign
    Tassew, Habtamu Abie
    Alemu, Asrat
    IJID REGIONS, 2023, 6 : 120 - 124
  • [27] COVID-19 vaccine hesitancy in the UK: a longitudinal household cross-sectional study
    Chaudhuri, Kausik
    Chakrabarti, Anindita
    Chandan, Joht Singh
    Bandyopadhyay, Siddhartha
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [28] The Health Belief Model Applied to COVID-19 Vaccine Hesitancy: A Systematic Review
    Limbu, Yam B.
    Gautam, Rajesh K.
    Pham, Long
    VACCINES, 2022, 10 (06)
  • [29] Investigation on the hesitancy of COVID-19 vaccination among liver transplant recipients: A cross-sectional study in China
    Pan, Yixiao
    Gong, Shiming
    Zhu, Xinye
    Xue, Chuqing
    Jing, Yilei
    Sun, Yinghua
    Qian, Yongbing
    Zhang, Jianjun
    Xia, Qiang
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [30] COVID-19 vaccination and concerns regarding vaccine hesitancy after the termination of the zero-COVID policy in China: A nationwide cross-sectional study
    Yang, Min
    Ma, Wenjuan
    Jiang, Jingfeng
    Lu, Zhen
    Wang, Xuwen
    Shen, Yuan
    Zou, Huachun
    Meng, Xiaojun
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)